Zydus Lifesciences Ltd share price logo

Zydus Lifesciences Share Price

NSE: ZYDUSLIFE

BSE: 532321

Mid Cap

Healthcare Sector

₹984.15

+3.10

(+0.32%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Fundraising Alert

Zydus Lifesciences' board to meet on November 6 to consider raising up to ₹5,000 crore through QIP, rights issue, or private placement.

Zydus Lifesciences Stock Performance

as on November 4, 2025 at 10:00 am IST

  • Day's Low

    Day's High

    ₹977.7
    ₹987.6
    downward going graph

    0.66%

    Downside

    0.35%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹795
    ₹1,059.05
    downward going graph

    19.22%

    Downside

    7.61%

    Upside

    downward going graph

Zydus Lifesciences share price movements today

Previous Close
₹981.05
Open
₹984.20
Volume
88.56K
Upper Circuit
₹1,079.15
Lower Circuit
₹882.95
Day's Low - High
₹977.7 - ₹987.6
52 Week Low - High
₹795 - ₹1,059.05

Zydus Lifesciences Historical Returns

1 Month Return
-1.37 %
3 Month Return
+ 2.32 %
1 Year Return
-2.33 %
3 Year Return
+ 122.92 %
5 Year Return
+ 123.32 %

Zydus Lifesciences Fundamentals

as on November 4, 2025 at 10:00 am IST

Market Cap

₹98,716.59 Cr

Return on Equity (ROE)

31.29

PE Ratio (TTM)

21.59

Return on capital employed (ROCE)

30.47

Industry PE ratio

41.74

Beta (LTM)

0.87

P/B Ratio

4.2

Dividend Yield

1.24

PEG Ratio

5.48

Quarterly Earnings Growth YOY

1.57

EPS (TTM)

45.87

Sector

Pharmaceuticals

Book Value

238.1

Technical Analysis

Bearish

View Technical Analysis

Zydus Lifesciences Stock Valuation

as on November 4, 2025 at 10:00 am IST

Zydus Lifesciences in the last 5 years

  • Overview

  • Trends

Lowest (7.34x)

March 7, 2022

Today (21.59x)

November 3, 2025

Industry (41.74x)

November 3, 2025

Highest (34.62x)

March 26, 2024

LowHigh

Today’s Price to Earnings Ratio: 21.59x

Zydus Lifesciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zydus Lifesciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD98,716.5924.66%0.614,61423,241
Sanofi India Ltd image
Sanofi India Ltd
BUY11,015.02-8.47%0.524132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY67,886.859.64%0.603,48331,723
Abbott India Ltd image
Abbott India Ltd
BUY61,699.3816.6%0.001,4146,445
Glaxosmithkline Pharmaceuticals Ltd image
Glaxosmithkline Pharmaceuticals Ltd
BUY45,448.2518.45%0.569273,749
See all

Analyst Recommendation on Zydus Lifesciences Stock

Based on 30 analysts

HOLD

40.00%

Buy

33.33%

Hold

26.67%

Sell

Based on 30 analysts, 40% of analysts recommend a 'HOLD' rating for Zydus Lifesciences. Average target price of ₹1020.03

Source: S&P Global Market Intelligence

Zydus Lifesciences Share Price Target

Get share price movements and forecasts by analysts on Zydus Lifesciences.

What analysts predicted

3.97%UPSIDE

Target Price

₹1020.03

Current Price

₹984.15

Analyzed by

30 Analysts

High

₹1255

Target

₹1020.03

Low

₹850

Zydus Lifesciences target price ₹1020.03, a slight upside of 3.97% compared to current price of ₹984.15. According to 30 analysts rating.

Source: S&P Global Market Intelligence

Zydus Lifesciences Stock’s Investor Sentiment and Interest

Investment in Zydus Lifesciences Ltd Shares on INDmoney has dropped by -28.77% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-28.77% versus previous 30 day period

Search interest for Zydus Lifesciences Ltd Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-25% versus previous 30 day period

Zydus Lifesciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
4,159.8
4,852.5
5,052.8
4,258.6
4,343.7
5,366.4
6,046.5
5,113.6
5,123.5
6,290.2
6,467
Other Income
38.9
37.8
36
54
59.5
159.6
63.2
68.5
57.5
80.6
154.9
Total Income
4,296
5,048.4
5,175.6
4,422.8
4,564.7
5,693.4
6,270.7
5,305.5
5,326.6
6,608.5
6,728.6
Expenses
3,301.1
4,358.5
3,649.5
3,223.7
3,402.8
3,903.3
4,123.5
3,775.6
3,881.8
4,622
4,485.2
Operating Profit
858.7
494
1,403.3
1,034.9
940.9
1,463.1
1,923
1,338
1,241.7
1,668.2
1,981.8
Operating Profit Margin %
20.64%
10.18%
27.77%
24.3%
21.66%
27.26%
31.8%
26.17%
24.24%
26.52%
30.64%
Profit Before Interest, Tax and Depreciation
994.9
689.9
1,526.1
1,199.1
1,161.9
1,790.1
2,147.2
1,529.9
1,444.8
1,986.5
2,243.4
Interest
32.8
27.7
18.1
8.7
19.8
34.6
32.2
25.1
32
76.6
84.7
Depreciation
181.6
178.6
179.8
184.2
194.8
205.3
215.3
233.6
229
237.9
238.1
Profit Before Tax
780.5
483.6
1,328.2
1,006.2
947.3
1,550.2
1,899.7
1,271.2
1,183.8
1,672
1,920.6
Tax Paid
195.2
137.2
216.1
226.4
213.8
321.2
436.1
373.1
179.5
423.2
434
Profit After Tax
585.3
346.4
1,112.1
779.8
733.5
1,229
1,463.6
898.1
1,004.3
1,248.8
1,486.6
Total Net profit including share of profit / Loss from associate company
631.2
358.2
1,133.6
803.2
789.9
1,246.1
1,482.5
920.2
1,026.2
1,243.7
1,521
EPS
6.15
2.93
10.74
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
Actual EPS
6.15
2.93
10.74
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
Adjusted EPS
6.15
2.93
10.74
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
Diluted EPS
6.15
2.93
10.74
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58

Zydus Lifesciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
9,167.3
11,581.3
12,748.4
13,812.1
14,125
14,827.6
16,877.8
19,021.5
22,573.8
Other Income
128.4
113.2
201.1
113.9
45.6
2,583.1
186.6
307.1
269.5
Total Income
9,504.9
12,018.1
13,366.7
14,367
14,449.1
17,693
17,424
19,854.5
23,511
Expenses
7,475.1
9,076.2
10,192.5
11,833.3
11,289.5
11,769.2
13,986.3
14,177.3
16,402.6
Operating Profit
1,692.2
2,505.1
2,555.9
1,978.8
2,835.5
3,058.4
2,891.5
4,844.2
6,171.2
Operating Profit Margin %
18.46%
21.63%
20.05%
14.33%
20.07%
20.63%
17.13%
25.47%
27.34%
Profit Before Interest, Tax and Depreciation
2,029.8
2,941.9
3,174.2
2,533.7
3,159.6
5,923.8
3,437.7
5,677.2
7,108.4
Interest
44.6
91.1
193.5
341.8
158.8
127
129.9
81.2
165.9
Depreciation
373.3
538.8
598.6
696.5
669.6
713
722.7
764.1
915.8
Profit Before Tax
1,611.9
2,312
2,382.1
1,495.4
2,331.2
5,083.8
2,585.1
4,831.9
6,026.7
Tax Paid
128.9
564.4
530.3
319.8
193.6
511.7
587.8
977.5
1,411.9
Profit After Tax
1,483
1,747.6
1,851.8
1,175.6
2,137.6
4,572.1
1,997.3
3,854.4
4,614.8
Total Net profit including share of profit / Loss from associate company
1,516.8
1,810.4
1,898.7
1,204.4
2,185
4,618.3
2,091.9
3,972.8
4,672.6
EPS
14.53
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
Actual EPS
14.53
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
Adjusted EPS
14.53
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
Diluted EPS
14.53
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97

Zydus Lifesciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1,893.5
1,311.7
919.3
1,281.9
2,931.5
3,293.9
2,104.5
2,688.8
3,196.3
6,776.7
Cash Flow from Investing Activities
-859.6
-2,871.9
-973.7
-3,977.4
-1,004.4
-836.7
-1,017.6
1,541.6
-1,492.3
-8,377.1
Cash Flow from Financing Activities
-934.8
2,315.8
51.5
1,884.6
-1,528.2
-2,547.7
-868.3
-4,400.4
-1,778.8
2,014.2
Net Cash Flow
99.1
755.6
-2.9
-810.9
398.9
-90.5
218.6
-170
-74.8
413.8

Zydus Lifesciences Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
74.98%
74.98%
74.98%
74.98%
74.98%
74.98%
74.98%
74.98%
74.98%
74.99%
74.99%
74.99%
DII
13.69%
13.6%
13.23%
13.09%
12.79%
12.63%
12.64%
10.65%
10.65%
11.01%
11.13%
10.86%
FII
0%
0%
0%
0%
0%
5.72%
5.59%
7.52%
7.53%
7.32%
7.13%
7.34%
Public
8.81%
8%
7.47%
7.07%
6.99%
6.66%
6.8%
6.85%
6.84%
6.68%
6.74%
6.8%
Total Outstanding Shares
1,01,22,04,139
1,01,22,04,139
1,01,22,04,139
1,01,22,04,139
1,01,22,04,139
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
Total Shareholders
3,70,396
3,38,570
3,11,764
2,97,953
3,06,495
2,94,324
3,36,309
3,70,863
3,65,356
3,71,619
3,86,127
3,96,105

Mutual Funds that own Zydus Lifesciences Stock

Check out the Mutual Funds with significant holdings in Zydus Lifesciences.

Zydus Lifesciences Corporate Actions

View detailed summary of the earnings and dividend history of Zydus Lifesciences.

  • Zydus Lifesciences Ltd Earnings Results

    Zydus Lifesciences Ltd’s net profit jumped 3.3% since last year same period to ₹1,466.80Cr in the Q1 2025-2026. On a quarterly growth basis, Zydus Lifesciences Ltd has generated 25.27% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Zydus Lifesciences Ltd Dividends May,2025

    In the quarter ending March 2025, Zydus Lifesciences Ltd has declared dividend of ₹11.00 per share on 19 May 2025 - translating a dividend yield of 1.13%.

    Read More about Dividends

Zydus Lifesciences News & Key Events

  • img

    Today's Timeline - 04 November

    08:37 AM

    -

    Zydus Lifesciences board to consider fundraising up to ₹5,000 crore on November 6.

Indices Featuring Zydus Lifesciences Stock

Check stock indices that include Zydus Lifesciences.

BSE Healthcare

₹45,029.09

-0.02 (▲-7.83%)

Nifty100 Eq Weig

₹34,026.20

-0.24 (▲-82.8%)

Nifty100 Quality

₹5,702.20

-0.47 (▲-26.95%)

BSE 200

₹11,698.18

-0.13 (▲-14.82%)

S&P BSE 150 MidCap

₹16,530.28

0.14 (▲23.21%)

S&P BSE 250 LargeMidCap

₹11,102.42

-0.11 (▲-12.69%)

Nifty Next 50

₹70,398.05

-0.12 (▲-85.25%)

Nifty LargeMidcap 250

₹16,751.20

-0.02 (▲-4%)

NIFTY 100

₹26,397.25

-0.18 (▲-48.6%)

NIFTY PHARMA

₹22,438.40

-0.02 (▲-4.2%)

Nifty Healthcare

₹14,843.50

0.05 (▲7.45%)

S&P BSE Dividend Stability

₹1,034.36

-0.37 (▲-3.89%)

Nifty 200

₹14,396.50

-0.14 (▲-19.85%)

S&P BSE 400 MidSmallCap

₹12,376.69

0.09 (▲11.48%)

S&P BSE Largecap

₹9,917.80

-0.18 (▲-17.53%)

Nifty 500

₹23,784.40

-0.11 (▲-26.3%)

BSE 500

₹37,324.31

-0.1 (▲-37.65%)

Insights on Zydus Lifesciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 5.30K Cr → 6.72K Cr (in ₹), with an average increase of 7.2% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 7.13% to 7.34% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 6.74% to 6.80% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ZYDUSLIFE has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 911.2 Cr → 1.46K Cr (in ₹), with an average increase of 14.6% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 74.99% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 14.2% return, outperforming this stock by 17.2%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 5.56% to 4.70% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ZYDUSLIFE stock has moved down by -3.9%

Zydus Lifesciences Stock Futures & Options Contracts

View the latest movement in Zydus Lifesciences Futures & Options, including strike prices, expiry dates, and percentage changes.

Zydus Lifesciences Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ZYDUSLIFE 25 Nov ₹1000 Call
November 25, 2025
₹1000
₹19.75
-0.05
-0.25%
ZYDUSLIFE 25 Nov ₹1120 Call
November 25, 2025
₹1120
₹1.1
-0.15
-12%
ZYDUSLIFE 25 Nov ₹990 Call
November 25, 2025
₹990
₹24.05
0
0%
ZYDUSLIFE 25 Nov ₹1020 Call
November 25, 2025
₹1020
₹13
-0.1
-0.76%

Zydus Lifesciences Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ZYDUSLIFE 25 Nov Fut
November 25, 2025
-
₹986.05
-0.99
-0.1%
ZYDUSLIFE 30 Dec Fut
December 30, 2025
-
₹991.65
-1.09
-0.11%
ZYDUSLIFE 27 Jan Fut
January 27, 2026
-
₹994.7
-0.9
-0.09%

About Zydus Lifesciences Ltd

Zydus Lifesciences Ltd is a leading pharmaceutical company headquartered in Ahmedabad, India. Incorporated in 1995, the company operates in a number of lines of business, including active pharmaceutical ingredients, formulations, biotechnology, and nutraceuticals.

The company has a strong presence in the global market and is known for its high-quality pharmaceutical products. It manufactures a wide range of generic and specialty drugs, including cardiovascular, anti-infective, anti-diabetic, and oncology medicines. Zydus also produces over-the-counter products and nutritional supplements. Some of its top products include Zetia, Atorvastatin, and Metformin.

Zydus Lifesciences Ltd is also known for its popular brands, such as Cadila, Nutralite, and Zydus Wellness. The company has a strong presence in the Indian market, with its products being sold in more than 20,000 stores across the country. It also exports its products to over 100 countries worldwide.

Revenue: ₹6,467.00Cr as on June 2025 (Q1 FY26)
Net Profit: ₹1,486.60Cr as on June 2025 (Q1 FY26)
Listing date: 18 Apr, 2000
Chairperson Name: Pankaj R Patel
OrganisationZydus Lifesciences Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOPankaj R Patel
E-voting on sharesClick here to vote

FAQs

What is Zydus Lifesciences share price today?

Zydus Lifesciences share price today stands at ₹984.15 as on . Zydus Lifesciences share today touched a day high of ₹987.6 and a low of ₹977.7.

What is the 52 week high and 52 week low range for Zydus Lifesciences share?

Zydus Lifesciences touched a 52 week high of ₹1059.05 and a 52 week low of ₹795. Zydus Lifesciences share price today i.e. is trending at ₹984.15, which is -7.07% down from its 52 week high and 23.79% up from its 52 week low.

What is Zydus Lifesciences's market capitalisation today?

Zydus Lifesciences market capitalisation is ₹98,716.59 Cr as on .

How to buy Zydus Lifesciences shares?

To buy Zydus Lifesciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ZYDUSLIFE or Zydus Lifesciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Zydus Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Zydus Lifesciences trading volume today?

Zydus Lifesciences trading volume is 88.56K as on . This means that 88.56K shares of Zydus Lifesciences were bought and sold on the stock market during today's trading session.